| Previous Close | 11.22 |
| Open | 11.26 |
| Bid | 7.15 x 100 |
| Ask | 21.01 x 200 |
| Day's Range | 11.15 - 11.41 |
| 52 Week Range | 10.27 - 22.46 |
| Volume | 219,891 |
| Avg. Volume | 311,234 |
| Market Cap | 336.02M |
| Beta | 1.18 |
| PE Ratio (TTM) | 31.89 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | 0.26 (2.39%) |
| Ex-Dividend Date | 2017-09-07 |
| 1y Target Est | N/A |
- Capital Cube•22 days ago
ETFs with exposure to Aceto Corp. : September 1, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Aceto Corp. Here are 5 ETFs with the largest exposure to ACET-US. Comparing the performance and risk of Aceto Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
- Zacks•24 days ago
Weakness Seen in Aceto Corporation (ACET) Estimates: Should You Stay Away?
Aceto Corporation (ACET) has witnessed a significant price decline in the past four weeks, and has seen negative earnings estimate revisions for the current quarter and year.
Capital Cube•25 days agoAceto Corp. :ACET-US: Earnings Analysis: Q4, 2017 By the Numbers : August 29, 2017
Categories: Yahoo FinanceGet free summary analysis Aceto Corp. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Aceto Corp. – Cambrex Corporation, Innophos Holdings, Inc., Quaker Chemical Corporation, Valeant Pharmaceuticals International Inc, Pfizer Inc., Merck & Co., Inc., Novartis AG Sponsored ADR, Teva Pharmaceutical Industries Limited ... Read more (Read more...)
